News

International Bladder Cancer Group partners with UroToday

The partnership will leverage the strengths of both organisations to provide patients with access to the latest information and resources about bladder cancer

International Bladder Cancer Group (IBCG) and UroToday, a leading global resource for urology news and education, are proud to announce our formal partnership to collaborate on improving patient outreach and education on bladder cancer. The partnership will leverage the strengths of both organisations to provide patients with access to the latest information and resources about bladder cancer.

THIS CAN BE YOUR ADVERTISEMENT

The IBCG is a globally recognised organisation dedicated to improving the care of patients with bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment. UroToday is a leading provider of urology news and education, reaching over 500,000 urologists and healthcare professionals worldwide.

Our two organisations have a decades-long history of collaboration, having worked together on numerous projects in the past. These projects have included the development of educational materials and the publication of peer-reviewed articles.

Our formal partnership will expand upon these existing efforts and will focus on the following key areas:

  • Developing and disseminating educational materials for patients about bladder cancer
  • Increasing patient awareness of clinical trials and other research opportunities
  • Advocating for patients at the national and international levels

“We are excited to formalise our partnership with UroToday,” says Dr Ashish M Kamat, President, IBCG. “This partnership will allow us to reach a wider audience of patients and provide them with the information they need to make informed decisions about their care.”

“We have enjoyed a long relationship of covering the work of the IBCG,” says Gina Carithers, CEO, UroToday. “We share the IBCG’s commitment to improving the care of patients with bladder cancer, and we believe that this partnership has the potential to make a real difference in the lives of patients.”

Our partnership with the IBCG is a significant step forward in the fight against bladder cancer. By working together, we are hopeful that our two organisations can help to improve the care and outcomes for patients with bladder cancer.

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close